X-Energy (XE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 May, 2026Strategic focus and business model
Specializes in licensing advanced small modular reactor (SMR) technology and providing engineering and lifecycle services, without engaging in EPC, construction, or energy generation.
Manufactures and sells proprietary TRISO-X nuclear fuel, with in-house fabrication and recurring revenue expected over a reactor's 60-year lifespan.
Revenue streams include technology and services fees, and long-term fuel supply, with estimated total revenue per 320 MWe plant ranging from $2.4B to $4.7B.
Business model minimizes capital requirements post-design and engineering, and avoids construction, inventory, and financing risks.
Technology and innovation
Xe-100 is a Gen IV high-temperature gas-cooled reactor with modular 320 MWe design, offering high safety, scalability, and over 95% availability.
Utilizes robust, proprietary TRISO-X pebble fuel, designed for high burn-up and intrinsic safety, with each reactor core containing ~220,000 pebbles.
Fuel fabrication pilot facility operational since 2016; first commercial facility (TX-1) in Oak Ridge, TN, is over 50% constructed and targets operations in 2028.
TX-1 and TX-2 facilities received the first-ever NRC Category II license for advanced nuclear fuel fabrication.
Market opportunity and customer base
Positioned to address ~$2.3 trillion revenue potential in US/Canada/UK SMR markets by 2050, driven by industrial and AI-related electricity demand growth.
Blue-chip customers and partners include Dow, Amazon, and Centrica, with visibility to 11.5 GW across 144 reactors.
First projects underway in Texas, Washington, and the UK, with regulatory reviews and construction progressing.
Latest events from X-Energy
- Q2 2026 revenue rose 154% YoY, with $1.1B IPO proceeds and major supply chain milestones.XE
Q2 2026 - Q1 revenues up 109% YoY, $1.1B IPO completed, liquidity at $2B, and major milestones achieved.XE
Q1 2026 - IPO targets $693.8M to scale advanced nuclear reactors and fuel, with major growth and risk.XE
Registration filing - IPO targets $693.8M to fund advanced nuclear growth, with strong market potential and significant execution risks.XE
Registration filing - IPO aims to fund advanced nuclear reactor and fuel commercialization amid high growth and risk.XE
Registration filing - IPO funds will drive SMR and fuel commercialization amid high growth and execution risks.XE
Registration filing - IPO targets SMR and fuel commercialization in a vast market, but faces high execution risk.XE
Registration filing